Acupuncture and exercise join forces against chemotherapy nerve pain

NCT ID NCT07700901

Not yet recruiting Symptom relief Sponsor: Show Chwan Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether combining electro-acupuncture with a structured exercise program helps cancer survivors manage chemotherapy-induced peripheral neuropathy (CIPN) — nerve damage causing numbness, pain, and balance problems in hands and feet. Participants receive either electro-acupuncture alone or electro-acupuncture plus exercise over 8 weeks. The goal is to see if the combination improves nerve symptoms, balance, and quality of life better than acupuncture alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: electroacupuncture and a structured exercise program
What this could lead to: If it works, this could offer a drug-free way to reduce nerve pain and improve balance for cancer survivors.
What could go wrong: This is a small, early-stage trial with 82 participants, so results may not apply to everyone. The combination may not prove better than electroacupuncture alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer chemotherapy-induced neuropathy neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

ShowChwanMH

Changhua, Changhua, 500, Taiwan

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.